+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lipid Nanoparticles Market - Global Forecast 2025-2030- Product Image
Lipid Nanoparticles Market - Global Forecast 2025-2030- Product Image
Sale

Lipid Nanoparticles Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016123
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The lipid nanoparticles market is experiencing rapid evolution, driven by expanding applications across medical, biotechnological, and personal care sectors. With ongoing innovation in delivery systems and advances in manufacturing processes, industry leaders are continuously reevaluating strategies to capture growth and maintain a competitive edge.

Market Snapshot: Lipid Nanoparticles Market Size and Growth

The Lipid Nanoparticles Market grew from USD 854.13 million in 2024 to USD 903.41 million in 2025. It is expected to continue growing at a CAGR of 5.82%, reaching USD 1.19 billion by 2030. Heightened demand arises from the pivotal role of lipid nanoparticles in advanced drug delivery, diagnostics, and genetic therapies. Market expansion reflects industry's push for improved targeted delivery and broader, more agile commercialization platforms.

Lipid Nanoparticles Market: Scope & Segmentation

This comprehensive report analyzes trends, opportunities, and challenges across all core segments and geographies covering the full landscape of the lipid nanoparticles market.

  • Lipid Source: Natural lipid nanoparticles, synthetic lipid nanoparticles.
  • Nanoparticle Type: Anionic, cationic, ionizable, neutral, PEGylated.
  • Preparation Method: Emulsification-solvent evaporation, high-pressure homogenization, microfluidics, single-step nanoprecipitation, solvent injection method.
  • Formulation: Nanostructured lipid carriers, solid lipid nanoparticles.
  • Size Range: Less than 100nm, 100–200nm, more than 200nm.
  • Functionalities: Controlled release, enhanced bioavailability, targeted delivery.
  • Application Areas: Diagnostic imaging, anticancer drug delivery, gene therapy, vaccines, nutrient encapsulation for food fortification, personal care.
  • End-User Industry: Academic and research centers, biotechnology companies, pharmaceutical companies.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, and others).
  • Key Industry Players: Acuitas Therapeutics, Alnylam Pharmaceuticals, Arcturus Therapeutics, Avanti Polar Lipids, BioNTech, Corden Pharma, CureVac, Danaher, Entos Pharmaceuticals, Etherna Immunotherapies, Evonik Industries, FUJIFILM Holdings, Generation Bio, Genevant Sciences, GlaxoSmithKline, GreenLight Biosciences, Merck KGaA, METiS Pharmaceuticals, Moderna, Nitto Denko, Pfizer, Polymun Scientific, RiboPro, Silence Therapeutics, Translate Bio, VBI Vaccines, Wacker Chemie.

Key Takeaways for Senior Decision-Makers

  • Lipid nanoparticles are redefining precision and efficacy in mRNA vaccines, gene therapies, and targeted drug delivery by enabling stable and controlled release of therapeutic agents.
  • Technological progress in microfluidics and single-step nanoprecipitation is significantly improving manufacturing consistency and efficiency, reducing production variability and material waste.
  • Recent regulatory adjustments, especially in North America and Europe, are intensifying quality control demands, compelling manufacturers to adopt robust characterization and process monitoring frameworks.
  • Collaboration between industry and academia is deepening, fostering more rapid development and translation of new formulations into clinical and commercial pipelines.
  • The market’s segmentation by lipid source, size, and function allows end users to tailor solutions closely to therapeutic, diagnostic, or nutritional objectives, supporting a highly differentiated market landscape.

Tariff Impact on Lipid Nanoparticle Components

Impending United States tariff changes in 2025 will affect imports of essential lipid nanoparticle components, including both natural and synthetic lipids. These policy shifts will increase upstream acquisition costs and exert pressure on pharmaceutical and biotech supply chains. Companies with onshore manufacturing or local sourcing partnerships are better positioned to mitigate risk and maintain operational stability. Strategic alliances and targeted investments in domestic production can further support resilience in the face of this evolving regulatory environment.

Market Research Methodology & Data Sources

This analysis integrates primary and secondary research, with insights derived from peer-reviewed publications, regulatory filings, patent databases, and direct interviews with lipid nanoparticle formulation experts, R&D engineers, and organizational strategists. All findings have been validated through multi-layered triangulation and stakeholder review, ensuring accuracy and relevance.

Lipid Nanoparticles Market: Why This Report Matters

  • Provides comprehensive market intelligence to inform strategic investment, R&D direction, and operational planning tailored for decision-makers in the pharmaceutical and biotechnology sectors.
  • Enables early risk identification related to shifting tariffs, regulatory pressures, and emerging technology trends, facilitating proactive strategy development and market entry planning.
  • Offers actionable segmentation and competitor benchmarking, supporting business units in optimizing product portfolios and identifying opportunities in new target markets.

Conclusion

The lipid nanoparticles market is defined by rapid innovation, expanding application fields, and evolving regulatory frameworks. Decision-makers who adapt strategies and cultivate the right partnerships will capture substantial opportunity as new commercial and therapeutic avenues continue to emerge.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in ionizable lipid design to improve endosomal escape and reduce toxicity leading to enhanced mRNA delivery efficiency
5.2. Growing partnerships between pharmaceutical companies and lipid nanoparticle developers to accelerate nucleic acid therapeutics pipelines
5.3. Scale-up challenges and innovative microfluidic manufacturing solutions for large-scale lipid nanoparticle production
5.4. Regulatory harmonization efforts to standardize lipid nanoparticle characterization and quality control across global markets
5.5. Emergence of targeted lipid nanoparticle formulations for tissue-specific mRNA delivery in oncology and rare diseases
5.6. Increasing demand for thermostable lipid nanoparticle vaccines enabling distribution in low-resource settings without cold chain
5.7. Integration of artificial intelligence in lipid formulation optimization for rapid screening and personalized nanocarrier design
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lipid Nanoparticles Market, by Source
8.1. Introduction
8.2. Natural Lipid Nanoparticles
8.3. Synthetic Lipid Nanoparticles
9. Lipid Nanoparticles Market, by Type
9.1. Introduction
9.2. Anionic Lipid Nanoparticles
9.3. Cationic Lipid Nanoparticles
9.4. Ionizable Lipid Nanoparticles
9.5. Neutral Lipid Nanoparticles
9.6. PEGylated Lipid Nanoparticles
10. Lipid Nanoparticles Market, by Method Of Preparation
10.1. Introduction
10.2. Emulsification-Solvent Evaporation
10.3. High-Pressure Homogenization
10.4. Microfluidics
10.5. Single-Step Nanoprecipitation
10.6. Solvent Injection Method
11. Lipid Nanoparticles Market, by Formulation
11.1. Introduction
11.2. Nanostructured Lipid Carriers
11.3. Solid Lipid Nanoparticles
12. Lipid Nanoparticles Market, by Size Range
12.1. Introduction
12.2. 100nm - 200nm
12.3. Less Than 100nm
12.4. More Than 200nm
13. Lipid Nanoparticles Market, by functionality
13.1. Introduction
13.2. Controlled Release
13.3. Enhanced Bioavailability
13.4. Targeted Delivery
14. Lipid Nanoparticles Market, by Applications
14.1. Introduction
14.2. Diagnostic Imaging
14.3. Drug Delivery
14.3.1. Anticancer Drugs
14.3.2. Gene Therapy Products
14.3.3. Vaccines
14.4. Nutrient Encapsulation & Food Fortification
14.5. Personal Care
15. Lipid Nanoparticles Market, by End-User Industry
15.1. Introduction
15.2. Academic & Research Centers
15.3. Biotechnology Companies & Institutes
15.4. Pharmaceutical Companies
16. Americas Lipid Nanoparticles Market
16.1. Introduction
16.2. United States
16.3. Canada
16.4. Mexico
16.5. Brazil
16.6. Argentina
17. Europe, Middle East & Africa Lipid Nanoparticles Market
17.1. Introduction
17.2. United Kingdom
17.3. Germany
17.4. France
17.5. Russia
17.6. Italy
17.7. Spain
17.8. United Arab Emirates
17.9. Saudi Arabia
17.10. South Africa
17.11. Denmark
17.12. Netherlands
17.13. Qatar
17.14. Finland
17.15. Sweden
17.16. Nigeria
17.17. Egypt
17.18. Turkey
17.19. Israel
17.20. Norway
17.21. Poland
17.22. Switzerland
18. Asia-Pacific Lipid Nanoparticles Market
18.1. Introduction
18.2. China
18.3. India
18.4. Japan
18.5. Australia
18.6. South Korea
18.7. Indonesia
18.8. Thailand
18.9. Philippines
18.10. Malaysia
18.11. Singapore
18.12. Vietnam
18.13. Taiwan
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Acuitas Therapeutics Inc.
19.3.2. Alnylam Pharmaceuticals, Inc.
19.3.3. Arcturus Therapeutics Holdings Inc. by Alcobra Ltd.
19.3.4. Avanti Polar Lipids, LLC by Croda International Plc
19.3.5. BioNTech SE
19.3.6. Corden Pharma International GmbH
19.3.7. CureVac SE
19.3.8. Danaher Corporation
19.3.9. Entos Pharmaceuticals
19.3.10. Etherna Immunotherapies Nv
19.3.11. Evonik Industries AG
19.3.12. FUJIFILM Holdings Corporation
19.3.13. Generation Bio Co.
19.3.14. Genevant Sciences Corporation
19.3.15. GlaxoSmithKline PLC
19.3.16. GreenLight Biosciences, Inc.
19.3.17. Merck KGaA
19.3.18. METiS Pharmaceuticals
19.3.19. Moderna Inc.
19.3.20. Nitto Denko Corporation
19.3.21. Pfizer Inc.
19.3.22. Polymun Scientific Immunbiologische Forschung GmbH
19.3.23. RiboPro
19.3.24. Silence Therapeutics PLC
19.3.25. Translate Bio Inc by Sanofi S.A.
19.3.26. VBI Vaccines Inc.
19.3.27. Wacker Chemie AG
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. LIPID NANOPARTICLES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LIPID NANOPARTICLES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. LIPID NANOPARTICLES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. LIPID NANOPARTICLES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 31. LIPID NANOPARTICLES MARKET: RESEARCHAI
FIGURE 32. LIPID NANOPARTICLES MARKET: RESEARCHSTATISTICS
FIGURE 33. LIPID NANOPARTICLES MARKET: RESEARCHCONTACTS
FIGURE 34. LIPID NANOPARTICLES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LIPID NANOPARTICLES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIPID NANOPARTICLES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LIPID NANOPARTICLES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NATURAL LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NATURAL LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SYNTHETIC LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SYNTHETIC LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ANIONIC LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ANIONIC LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY CATIONIC LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY CATIONIC LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY IONIZABLE LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY IONIZABLE LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NEUTRAL LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NEUTRAL LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY PEGYLATED LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY PEGYLATED LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY EMULSIFICATION-SOLVENT EVAPORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY EMULSIFICATION-SOLVENT EVAPORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY HIGH-PRESSURE HOMOGENIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY HIGH-PRESSURE HOMOGENIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SINGLE-STEP NANOPRECIPITATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SINGLE-STEP NANOPRECIPITATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOLVENT INJECTION METHOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOLVENT INJECTION METHOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NANOSTRUCTURED LIPID CARRIERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NANOSTRUCTURED LIPID CARRIERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOLID LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SOLID LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY 100NM - 200NM, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY 100NM - 200NM, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY LESS THAN 100NM, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY LESS THAN 100NM, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY MORE THAN 200NM, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY MORE THAN 200NM, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ENHANCED BIOAVAILABILITY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ENHANCED BIOAVAILABILITY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ANTICANCER DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ANTICANCER DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NUTRIENT ENCAPSULATION & FOOD FORTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY NUTRIENT ENCAPSULATION & FOOD FORTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY PERSONAL CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY PERSONAL CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY ACADEMIC & RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES & INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES & INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LIPID NANOPARTICLES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES LIPID NANOPARTICLES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 127. CANADA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 128. CANADA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 129. CANADA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 134. CANADA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 135. CANADA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 136. CANADA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 137. CANADA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 138. CANADA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 139. CANADA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 140. CANADA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 141. CANADA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 142. CANADA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 143. CANADA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 144. CANADA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 145. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 150. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 151. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 152. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 153. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 154. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 155. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 156. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 157. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 162. MEXICO LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA LIPID NANOPARTICLES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 237. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 238. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 239. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 242. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 243. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 244. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 245. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 246. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 248. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 249. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 250. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 251. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 252. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 253. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 254. GERMANY LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 255. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 256. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 257. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 260. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 261. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 262. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 263. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 264. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 265. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 266. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 267. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 268. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 269. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 270. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 271. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 272. FRANCE LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 285. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 286. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 291. ITALY LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 292. ITALY LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 293. ITALY LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 294. ITALY LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 295. ITALY LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 296. ITALY LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 297. ITALY LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 298. ITALY LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 299. ITALY LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 300. ITALY LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 301. ITALY LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 302. ITALY LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 303. ITALY LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 304. ITALY LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 305. ITALY LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 306. ITALY LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 307. ITALY LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 308. ITALY LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 309. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 310. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 311. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 312. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 313. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 314. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 315. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 316. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 317. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024 (USD MILLION)
TABLE 318. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2025-2030 (USD MILLION)
TABLE 319. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2018-2024 (USD MILLION)
TABLE 320. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY FUNCTIONALITY, 2025-2030 (USD MILLION)
TABLE 321. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 322. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 323. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 324. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 325. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2018-2024 (USD MILLION)
TABLE 326. SPAIN LIPID NANOPARTICLES MARKET SIZE, BY END-USER INDUSTRY, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY METHOD OF PREPARATION, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES LIPID NANOPARTICLES MARKET SIZE, BY SIZE RANGE, 2018-2024

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Lipid Nanoparticles market report include:
  • Acuitas Therapeutics Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Arcturus Therapeutics Holdings Inc. by Alcobra Ltd.
  • Avanti Polar Lipids, LLC by Croda International Plc
  • BioNTech SE
  • Corden Pharma International GmbH
  • CureVac SE
  • Danaher Corporation
  • Entos Pharmaceuticals
  • Etherna Immunotherapies Nv
  • Evonik Industries AG
  • FUJIFILM Holdings Corporation
  • Generation Bio Co.
  • Genevant Sciences Corporation
  • GlaxoSmithKline PLC
  • GreenLight Biosciences, Inc.
  • Merck KGaA
  • METiS Pharmaceuticals
  • Moderna Inc.
  • Nitto Denko Corporation
  • Pfizer Inc.
  • Polymun Scientific Immunbiologische Forschung GmbH
  • RiboPro
  • Silence Therapeutics PLC
  • Translate Bio Inc by Sanofi S.A.
  • VBI Vaccines Inc.
  • Wacker Chemie AG

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 903.41 Million
Forecasted Market Value ( USD ) by 2030 $ 1190 Million
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Lipid Nanoparticle Formulation Market - Global Forecast 2025-2030 - Product Image

Lipid Nanoparticle Formulation Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Liposomal & Lipid Nanoparticle Drug Delivery Systems Market - Global Forecast 2025-2030 - Product Image

Liposomal & Lipid Nanoparticle Drug Delivery Systems Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Lipid Nanoparticle Market Size, Share & Trends Analysis Report by LNP (Liposomes, Nanostructured Lipid Carriers), Molecule (MRNA, SiRNA), Application, Indication, End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Lipid Nanoparticle Market Size, Share & Trends Analysis Report by LNP (Liposomes, Nanostructured Lipid Carriers), Molecule (MRNA, SiRNA), Application, Indication, End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Lipid Nanoparticle Manufacturing Market Report and Forecast 2025-2034 - Product Image

Lipid Nanoparticle Manufacturing Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Lipid Nanoparticle Manufacturing - Global Strategic Business Report - Product Image

Lipid Nanoparticle Manufacturing - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.